Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine versus risperidone in early psychosis: subjective well-being, cannabis craving, and adherence
NL-OMON22184Active, not recruiting
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in schizophrenia, schizoaffective disorder and schizophreniform disorder comparing Olanzapine with Risperidone (2 arms). Primary endpoints: Subjective Well-being under Neuroleptics scale, Obsessive Compulsive Drug Use Scale and 8 more. Started Jul 2003; status: active, not recruiting.
02
Drugs
olanzapinerisperidone
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NL-OMON22184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22184.